temozolomide · Merck Sharp Dohme · NDA 021029, 022277
Temodar
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 7
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021029 · 001 · RLD · discontinued | capsule, oral | 5MG | open |
| 021029 · 002 · RLD · discontinued | capsule, oral | 20MG | open |
| 021029 · 003 · RLD · discontinued | capsule, oral | 100MG | open |
| 021029 · 004 · RLD · discontinued | capsule, oral | 250MG | open |
| 021029 · 005 · RLD · discontinued | capsule, oral | 140MG | open |
| 021029 · 006 · RLD · discontinued | capsule, oral | 180MG | open |
| 022277 · 001 · RLD | powder, intravenous | 100MG/VIAL | open |